mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0009 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |